BACKGROUND: After pancreatic surgery hepaticojejunostomy (HJ) stricture is a rare condition. Usually, management is conservative, while operative revision ("redo") is only rarely performed. METHODS: This was an observational cohort design that analyzed the outcome of patients who had a surgical revision of HJ strictures after pancreatic surgery at a specialized pancreatic center. RESULTS: During a period of 7 years from January 2004 until December 2010, 887 patients underwent pancreaticoduodenectomy (PD) or HJ. Among this patient population, 3 % (23/887) underwent a redo of the HJ secondary to stricture formation. Major symptoms of HJ strictures were recurrent cholangitis in 91 % (21/23) and jaundice in 39 % (9/23). The median time from the index operation until redo of the HJ was 16 ± 27 months. The median survival of patients with malignancy after redo of the HJ was 45 ± 67 months. Major surgical morbidity was 9 % (2/23), and mortality was 0 % (0/23). In 78 % (18/23), there were no further episodes of cholangitis after a median follow of 49 ± 73 months, while none of the patients with redo of the HJ developed a restenosis of the HJ. CONCLUSION: Surgical revision (redo) of HJ strictures can be safely performed by an experienced pancreatic surgeon with a low morbidity without mortality with good long-term results.
BACKGROUND: After pancreatic surgery hepaticojejunostomy (HJ) stricture is a rare condition. Usually, management is conservative, while operative revision ("redo") is only rarely performed. METHODS: This was an observational cohort design that analyzed the outcome of patients who had a surgical revision of HJ strictures after pancreatic surgery at a specialized pancreatic center. RESULTS: During a period of 7 years from January 2004 until December 2010, 887 patients underwent pancreaticoduodenectomy (PD) or HJ. Among this patient population, 3 % (23/887) underwent a redo of the HJ secondary to stricture formation. Major symptoms of HJ strictures were recurrent cholangitis in 91 % (21/23) and jaundice in 39 % (9/23). The median time from the index operation until redo of the HJ was 16 ± 27 months. The median survival of patients with malignancy after redo of the HJ was 45 ± 67 months. Major surgical morbidity was 9 % (2/23), and mortality was 0 % (0/23). In 78 % (18/23), there were no further episodes of cholangitis after a median follow of 49 ± 73 months, while none of the patients with redo of the HJ developed a restenosis of the HJ. CONCLUSION: Surgical revision (redo) of HJ strictures can be safely performed by an experienced pancreatic surgeon with a low morbidity without mortality with good long-term results.
Authors: Gajanan D Wagholikar; Sadiq S Sikora; Rakesh Pandey; Kaushal K Prasad; Ashok Kumar; Rajan Saxena; Vinay K Kapoor Journal: Indian J Gastroenterol Date: 2003 Sep-Oct
Authors: Georgios C Sotiropoulos; George Sgourakis; Arnold Radtke; Ernesto P Molmenti; Konstantinos Goumas; Sofia Mylona; Ioannis Fouzas; Constantine Karaliotas; Hauke Lang Journal: Transplantation Date: 2009-06-15 Impact factor: 4.939
Authors: Marc F Catalano; Jeffrey D Linder; Suku George; Eduardo Alcocer; Joseph E Geenen Journal: Gastrointest Endosc Date: 2004-12 Impact factor: 9.427
Authors: Kaye M Reid-Lombardo; Antonio Ramos-De la Medina; Kristine Thomsen; William S Harmsen; Michael B Farnell Journal: J Gastrointest Surg Date: 2007-10-11 Impact factor: 3.452
Authors: Francesca M Dimou; Deepak Adhikari; Hemalkumar B Mehta; Kelly Olino; Taylor S Riall; Kimberly M Brown Journal: Surgery Date: 2016-07-06 Impact factor: 3.982
Authors: Sebastian Cammann; Kai Timrott; Ralf-Peter Vonberg; Florian W R Vondran; Harald Schrem; Sebastian Suerbaum; Jürgen Klempnauer; Hüseyin Bektas; Moritz Kleine Journal: Langenbecks Arch Surg Date: 2016-05-28 Impact factor: 3.445